Skip to main content
GlaxoSmithKline PLC logo

GlaxoSmithKline PLC — Investor Relations & Filings

Ticker · GSK ISIN · GB00BN7SWP63 LEI · 5493000HZTVUYLO1D793 IL Manufacturing
Open in API
Filings indexed 7,016 across all filing types
Latest filing 2026-03-18 Regulatory Filings
Country GB United Kingdom
Listing IL GSK

About GlaxoSmithKline PLC

https://www.gsk.com/en-gb/

GSK plc is a global biopharmaceutical company that unites science, technology, and talent to research, develop, and manufacture medicines and vaccines. The company focuses on preventing and treating disease across four primary therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Its portfolio consists of specialty medicines and vaccines aimed at addressing significant global health needs. GSK's strategy centers on leveraging its research and development capabilities to deliver new health solutions.

Recent filings

Filing Released Lang Actions
6-K - GSK plc (0001131399) (Filer)
Regulatory Filings
2026-03-18 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a notification of a transaction by a Person Discharging Managerial Responsibilities (PDMR), specifically Diana Conrad, Chief People Officer at GSK plc. It details the acquisition of American Depositary Shares (ADS) under a pension plan. This type of disclosure is a standard regulatory requirement for insider/director dealings in shares, which falls under the 'Director's Dealing' category.
2026-03-18 English
6-K - GSK plc (0001131399) (Filer)
Regulatory Filings
2026-03-18 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from GSK plc regarding the purchase of its own shares (share buyback). It includes specific details such as the date of purchase, the number of shares acquired, price information, and a detailed schedule of individual transactions. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS).
2026-03-18 English
6-K - GSK plc (0001131399) (Filer)
Regulatory Filings
2026-03-17 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a Person Discharging Managerial Responsibilities (PDMR), specifically Maya Martinez-Davis, President of US at GSK plc. It details the acquisition of American Depositary Shares (ADS) within an executive savings plan. This type of disclosure is a standard regulatory requirement for insider/director dealings, which falls under the 'Director's Dealing' category.
2026-03-17 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.